Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Respironics to be Covered by MMP™ Portfolio License Cool Each new License
4
Oct 20, 2008 12:05PM

Oct 20, 2008 05:06PM

IMO it's highly unlikely that the USPTO knows about or cares about license sales. They are not judging a popularity contest.

But the sales this SEP-NOV Q have been to large companies and that says a lot about what the lawyers for these companies think about the validity of the MMP.

The chart below shows: Draught (since last sale), Announcement Date, Company, and Annual Sales $.

We had a 42 day draught going from last Q into this Q before we had the first sale. The next sale (Respironics) was 18 days later. That's an awfully slow rate of sales, and it seems contrary to the fact that large companies continue to put money on the table - a clear DD vote that the MMP is valid.

But my estimates say we should be closing sales at 2 per week -TPL seems to have the capacity. So what's the hold up? I don't have a clue.

18 20-Oct-08 Respironics $1.2 billion
42 2-Oct-08 Rockwell Automation $5 billion


Share
New Message
Please login to post a reply